Isomorphic Labs
Senior Translational Oncologist leading the design and execution of translational strategy across an AI-driven oncology pipeline. The role partners closely with Computational Biology, AI/ML, Drug Design and Clinical teams and includes line management of a small biology team. The position focuses on defining the path to clinic, building biomarker and patient selection strategies, and ensuring preclinical findings translate into clinical candidates.
Headquarters
London, England, United Kingdom
Company Size
51-200 employees
Founded
2021
Isomorphic Labs is an AI-driven drug discovery company that applies frontier machine learning to reimagine the drug discovery process. Building on advances such as DeepMind’s AlphaFold, it uses protein-structure prediction, generative modeling, and computational biology to uncover deeper biological insights, design candidate molecules, and accelerate target selection. The company develops an integrated computational platform and partners with biopharma to translate in silico predictions into experimental programs aimed at faster, de‑risked development of life‑changing medicines. Its teams combine machine learning, biology, and chemistry expertise to shorten discovery timelines and increase the pace of therapeutic breakthroughs.
Google-backed Isomorphic Labs delays clinical trial timeline
1 month ago
Isomorphic Labs prepares to launch trials for AI-designed drugs
Jul 7, 2025
Isomorphic Labs has grand ambitions to 'solve all diseases' with AI. Now, it's gearing up for its first human trials
Jul 6, 2025
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Isomorphic Labs.
Isomorphic Labs didn’t post a salary, so this is our estimate from similar listings.
How AI Company Isomorphic Labs Is Working to Solve All Disease | Bloomberg Tech: Europe 9/12/2025
Sep 12, 2025
Director, Translational Biology
Vir Biotechnology
Intern, Translational Sciences
Revolution Medicines
Principal Scientist, Translational Computational Biology
Bristol Myers Squibb
Senior Scientist, Translational Computational Biology
Bristol Myers Squibb
Translational Specialist
Novo Nordisk A/S
Scientist II, Biomarker Sciences/Translational Sciences
Revolution Medicines